Nierengarten, 2003 - Google Patents
New approaches to generating semi-synthetic post-translationally modified proteinsNierengarten, 2003
- Document ID
- 10938904205835801086
- Author
- Nierengarten D
- Publication year
External Links
Snippet
Genetic engineering has opened countless doors in biological research. However, while we have near complete control over the amino acid sequence of a protein of interest, the same degree of control has not been exerted over the many post-translational modifications that …
- 102000035360 post-translationally modified proteins 0 title description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48369—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying part being an antibody, an immunoglobulin, or a fragment thereof, e.g. a Fc-fragment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Loo et al. | Prolonged association of temperature-sensitive mutants of human P-glycoprotein with calnexin during biogenesis. | |
| Grogan et al. | Homogeneous glycopeptides and glycoproteins for biological investigation | |
| US7259246B2 (en) | Immunological detection of prions | |
| US8080245B2 (en) | Anti-pathogen immunoadhesins | |
| JP2005500002A (en) | Compositions and methods for transporting biologically active agents across the cell barrier | |
| TR201815592T4 (en) | Serum amyloid β derivatives and their preparation and use. | |
| JPH11511034A (en) | Transgenic animals expressing proteins labeled with artificial epitopes | |
| RU2194713C2 (en) | Human modified protein c3, dna fragment, conjugate, pharmaceutical composition, method of decrease of protein amount content | |
| Zhang et al. | Targeting of functional antibody-CD59 fusion proteins to a cell surface | |
| CA1338878C (en) | 14-beta-gal mammalian lectins | |
| IBRAHIM et al. | Reproductive tract secretions and bull spermatozoa contain different clusterin isoforms that cluster cells and inhibit complement‐induced cytolysis | |
| Ball et al. | Engineering the prion protein using chemical synthesis | |
| US6221657B1 (en) | Modified human C3 DNA sequences and vectors | |
| Zenteno et al. | Chemical characterization of the lectin from the freshwater prawn Macrobrachium rosenbergii (De Man) by MALDI-TOF | |
| US5834593A (en) | Soluble form of PrPSC which is insoluble in native form | |
| Nierengarten | New approaches to generating semi-synthetic post-translationally modified proteins | |
| CZ283598A3 (en) | C3-convertase being resistant to regulating reduction of activity | |
| Wang et al. | Initiation of mucin-type O-glycosylation in Dictyostelium is homologous to the corresponding step in animals and is important for spore coat function | |
| US20040248257A1 (en) | SPEX compositions and methods of use | |
| Telling et al. | N‐terminally tagged prion protein supports prion propagation in transgenic mice | |
| Sakudo et al. | GPI-anchorless human prion protein is secreted and glycosylated but lacks superoxide dismutase activity | |
| RU2238322C2 (en) | Protein eliciting ability for formation of c3-convertase, dna, vector, conjugate and their using | |
| Clark et al. | Site-specific 32P-labeling of cytokines, monoclonal antibodies, and other protein substrates for quantitative assays and therapeutic application | |
| Ness | Investigation Of The Saccharomyces Cerevisiae Gpi Transamidase: Insights Into Its Activity And Subunit-Subunit Interactions | |
| CA2204995A1 (en) | Antibiotic cryptdin peptides and methods of their use |